Titan Partners Group, together with crypto investment firm, GSR - are spearheading the transformation of MEI Pharma (NASDAQ: MEIP) with the addition of a dedicated Litecoin treasury. Over US$100 million has already been committed.

Significantly, Charlie Lee, creator of Litecoin, has agreed to join the Board of Directors of MEI Pharma. Additionally, the Litecoin Foundation has also invested in MEI Pharma, as its treasury aligns with the Litecoin Foundation's core mission of driving the global adoption of Litecoin.

‍“For 14 years, Litecoin has consistently delivered a stable, low-cost, and accessible network for millions and over a decade. Already leading global transaction volume on platforms like BitPay, Litecoin is trusted as a legitimate payments alternative for remittance, cross-border and retail. by users and integrated across retail and payments. This partnership with GSR and MEI Pharma brings that utility and mission into an institutional setting for the first time." - Charlie Lee, Creator of Litecoin.

Since launching Litecoin in 2011, Lee has become one of cryptocurrency's most influential and respected figures. Lee has championed Litecoin’s innovation, ecosystem and continuous improvement ever since. From Litecoin’s opt-in privacy feature, to Litecoin’s activation of Segwit - and its subsequent adoption by Bitcoin, Lee has been instrumental. 

Much like the significant financial contribution to this Litecoin treasury, Lee has supported critical innovations within the Litecoin and Bitcoin ecosystems. Including various developmental  innovations, the Lightning Network, research and development labs, mining pools, and innumerable other projects contributing to the growth and maturity of Litecoin and Bitcoin.

No doubt Lee's extensive expertise, profile and leadership will prove invaluable to the success of this newly established Litecoin treasury.